Fig. 3D showed that fatty acid synthase (FAS), sterol regulatory element-binding protein (SREBP-1c), monocyte chemotactic protein-1 (MCP-1) and CD36 mRNA levels were notably reduced in notoginsenoside Fe-treated group compared with that in HF group. The gene discussed is CCL2; the disease is hydrops fetalis.